Inhibrx Biosciences, Inc.

NasdaqGS:INBX Stock Report

Market Cap: US$224.7m

Inhibrx Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:INBX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Sep 24BuyUS$629,117Mark LappeIndividual40,000US$17.13
11 Sep 24BuyUS$99,992Kristiina VuoriIndividual6,636US$15.07
10 Sep 24BuyUS$671,150Mark LappeIndividual44,000US$15.29
03 Sep 24BuyUS$596,763Mark LappeIndividual40,000US$16.31
29 Aug 24BuyUS$99,960Kristiina VuoriIndividual7,140US$14.00
28 Aug 24BuyUS$139,800Kimberly ManhardIndividual10,000US$13.98
23 Aug 24BuyUS$1,037,328Douglas ForsythIndividual75,000US$14.07
21 Aug 24BuyUS$518,282Mark LappeIndividual40,000US$12.97
05 Jun 24BuyUS$997,024John KayyemIndividual57,549US$17.89
04 Jun 24BuyUS$4,927,580John KayyemIndividual286,786US$18.24

Insider Trading Volume

Insider Buying: INBX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of INBX?
Owner TypeNumber of SharesOwnership Percentage
General Public843,4525.83%
VC/PE Firms1,064,0267.35%
Public Companies1,157,9268%
Hedge Funds1,787,70512.3%
Individual Insiders2,781,50119.2%
Institutions6,841,29447.3%

Dilution of Shares: INBX only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 82.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.4%
Viking Global Investors LP
1,787,705US$27.7m0%0.1%
8%
Sanofi
1,157,926US$18.0m0%no data
7.56%
John Kayyem
1,093,860US$17.0m0%no data
7.35%
Perceptive Advisors LLC
1,064,026US$16.5m0%0.36%
6.39%
Mark Lappe
925,413US$14.4m21.5%no data
4.72%
BlackRock, Inc.
683,075US$10.6m0%no data
3.55%
Brendan Eckelman
513,888US$8.0m0%no data
3.3%
The Vanguard Group, Inc.
478,028US$7.4m0%no data
3.28%
Walleye Capital LLC
474,999US$7.4m0%0.05%
3.2%
Sofinnova Investment, Inc.
463,315US$7.2m0%0.43%
2.36%
Slotnik Capital, LLC
341,605US$5.3m0%3.19%
2.11%
Alpine Associates Management Inc.
305,967US$4.7m0%0.24%
2.09%
Millennium Management LLC
303,196US$4.7m0%no data
1.68%
TIG Advisors, LLC
243,650US$3.8m0%0.25%
1.63%
Morgan Stanley, Investment Banking and Brokerage Investments
235,608US$3.7m0%no data
1.59%
Ikarian Capital, LLC
230,000US$3.6m0%1.03%
1.55%
Douglas Forsyth
224,564US$3.5m50.2%no data
1.45%
Geode Capital Management, LLC
210,317US$3.3m0%no data
1.38%
Caption Management, LLC
199,998US$3.1m0%0.32%
1.36%
Marshall Wace LLP
197,500US$3.1m0%no data
1.16%
Tang Capital Management, LLC
167,500US$2.6m0%0.23%
1.14%
Kennedy Capital Management LLC
164,971US$2.6m0%0.05%
1.05%
ArrowMark Colorado Holdings, LLC
152,159US$2.4m0%0.03%
1.03%
State Street Global Advisors, Inc.
148,586US$2.3m0%no data
0.98%
Qube Research & Technologies Ltd
141,400US$2.2m0%no data